Evidências sobre o tratamento da acne

Autores

  • Caroline Sousa Costa Escola Paulista de Medicina-Universidade Federal de São Paulo
  • Ediléia Bagatin Escola Paulista de Medicina-Universidade Federal de São Paulo

Palavras-chave:

Acne vulgar, Terapêutica, Medicina baseada em evidências, Antibacterianos, Isotretinoína

Resumo

Na terapêutica atual da acne vulgar, muitas opções amplamente praticadas carecem de respaldo em estudos de melhor nível de evidência científica. O objetivo desta revisão narrativa é apresentar o que há de mais recente no tratamento tópico e sistêmico da acne vulgar. São enfatizadas as informações de revisões sistemáticas e de ensaios clínicos com bom desenho metodológico, obtidas a partir de busca sistematizada nas principais bases de dados em medicina. Há importantes questões referentes à conduta clínica diante da acne que ainda requerem embasamento em evidências científicas consistentes, entre elas a dose e a duração ideais do tratamento com antibióticos orais, sem que ocorra indução de resistência bacteriana, e a segurança da isotretinoína oral.

Downloads

Não há dados estatísticos.

Biografia do Autor

Caroline Sousa Costa, Escola Paulista de Medicina-Universidade Federal de São Paulo

MD. Doctoral student in the Postgraduate Program on Internal Medicine and Therapeutics, Escola Paulista de Medicina — Universidade Federal de São Paulo (EPM-Unifesp), and Dermatologist at the STD/AIDS Reference and Training Center, Government of the State of São Paulo, São Paulo, Brazil.

Ediléia Bagatin, Escola Paulista de Medicina-Universidade Federal de São Paulo

MD, PhD. Dermatologist and Adjunct Professor, Department of Dermatology, Escola Paulista de Medicina — Universidade Federal de São Paulo (EPM-Unifesp), São Paulo, Brazil.

Referências

Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009;60(5 Suppl):S1-50.

National Institute of health and Clinical Excellence. Clinical Knowledge Summaries. Acne vulgaris – Management. Which scenario? Available from: http://www.cks.nhs.uk/acne_vulgaris. Accessed in 2012 (Aug 30).

Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(1 Suppl):S1-37.

Strauss JS, Krowchuk DP, Leyden JJ, et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol. 2007;56(4):651-63.

Nast A, Bayerl C, Borelli C, et al. S2k-leitlinie zur therapie der akne [S2k- guideline for therapy of acne]. J Dtsch Dermatol Ges. 2010;8 Suppl 2:s1-59.

Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet. 2012;379(9813):361-72.

Food and Drug Administration, HHS. Classification of benzoyl peroxide as safe and effective and revision of labeling to drug facts format; topical acne drug products for over-the-counter human use; final rule. Fed Regist. 2010;75(42):9767-77.

Fakhouri T, Yentzer BA, Feldman SR. Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability. J Drugs Dermatol. 2009;8(7):657-61.

Ozolins M, Eady EA, Avery AJ, et al. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet. 2004;364(9452): 2188-95.

Seidler EM, Kimball AB. Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne. J Am Acad Dermatol. 2010;63(1):52-62.

2010 Annual Evidence Update on Acne Vulgaris. Available from: http://www.nottingham.ac.uk/scs/documents/documentsdivisions/ documentsdermatology/methodologicalresources/2010-annual- evidence-update-on-acne-vulgaris.pdf. Accessed in 2012 (Aug 30).

Haider A, Shaw JC. Treatment of acne vulgaris. JAMA. 2004; 292(6):726-35.

Cunliffe WJ, Poncet M, Loesche C, Verschoore M. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials. Br J Dermatol. 1998;139 Suppl 52:48-56.

Yentzer BA, McClain RW, Feldman SR. Do topical retinoids cause acne to “flare”? J Drugs Dermatol. 2009;8(9):799-801.

Smith EV, Grindlay DJ, Williams HC. What’s new in acne? An analysis of systematic reviews published in 2009-2010. Clin Exp Dermatol. 2011;36(2):119-22; quiz 123.

Simonart T, Dramaix M. Treatment of acne with topical antibiotics: lessons from clinical studies. Br J Dermatol. 2005;153(2):395-403.

Iraji F, Sadeghinia A, Shahmoradi Z, Siadat AH, Jooya A. Efficacy of topical azelaic acid gel in the treatment of mild-moderate acne vulgaris. Indian J Dermatol Venereol Leprol. 2007;73(2):94-6.

Gollnick HP, Graupe K, Zaumseil RP. 5% Azelainsäuregel in der Behandlung der Akne. Zwei doppelblinde klinische Vergleichsstudien [Azelaic acid 15% gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies]. J Dtsch Dermatol Ges. 2004;2(10):841-7.

Graupe K, CunliffeWJ, Gollnick HP, Zaumseil RP. Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports. Cutis. 1996; 57(1 Suppl):20-35.

Webster GF. Evidence-based review: fixed-combination therapy and topical retinoids in the treatment of acne. J Drugs Dermatol. 2011;10(6):636-44.

Thiboutot D, Zaenglein A, Weiss J, et al. An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients. J Am Acad Dermatol. 2008;59(5):792-800.

Gollnick HP, Draelos Z, Glenn MJ, et al. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients. Br J Dermatol. 2009;161(5):1180-9.

Yentzer BA, Ade RA, Fountain JM, et al. Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trial. Cutis. 2010;86(2):103-8.

Guerra-Tapia A. Effects of benzoyl peroxide 5% clindamycin combination gel versus adapalene 0.1% on quality of life in patients with mild to moderate acne vulgaris: a randomized single-blind study. J Drugs Dermatol. 2012;11(6):714-22.

Keating GM. Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged  12 years. Am J Clin Dermatol. 2011;12(6):407-20.

Eady AE, Cove JH, Layton AM. Is antibiotic resistance in cutaneous propionibacteria clinically relevant?: implications of resistance for acne patients and prescribers. Am J Clin Dermatol. 2003;4(12):813-31.

Patel M, Bowe WP, Heughebaert C, Shalita AR. The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review. J Drugs Dermatol. 2010;9(6):655-64.

Simonart T, Dramaix M, De Maertelaer V. Efficacy of tetracyclines in the treatment of acne vulgaris: a review. Br J Dermatol. 2008;158(2): 208-16.

Garner SE, Eady EA, Popescu C, Newton J, Li WA. Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev. 2003;(1):CD002086.

Arowojolu AO, Gallo MF, Lopez LM, Grimes DA. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. 2012;7:CD004425.

Brown J, Farquhar C, Lee O, Toomath R, Jepson RG. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database Syst Rev. 2009;(2):CD000194.

Bernstein CN, Nugent Z, Longobardi T, Blanchard JF. Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study. Am J Gastroenterol. 2009;104(11):2774-8.

Crockett SD, Porter CQ, Martin CF, Sandler RS, Kappelman MD. Isotretinoin use and the risk of inflammatory bowel disease: a case- control study. Am J Gastroenterol. 2010;105(9):1986-93.

Marqueling AL, Zane LT. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg. 2005;24(2):92-102.

Sundström A, Alfredsson L, Sjölin-Forsberg G, et al. Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study. BMJ. 2010;341:c5812.

Kontaxakis VP, Skourides D, Ferentinos P, Havaki-Kontaxaki BJ, Papadimitriou GN. Isotretinoin and psychopathology: a review. Ann Gen Psychiatry. 2009;8:2.

Costa CS, Bagatin E, da Silva EMK, et al. Oral isotretinoin for acne. The Cochrane Library. 2011;(11):CD009435. Available from: http:// onlinelibrary.wiley.com/doi/10.1002/14651858.CD009435/abstract. Accessed in 2012 (Aug 31).

Hamilton FL, Car J, Lyons C, et al. Laser and other light therapies for the treatment of acne vulgaris: systematic review. Br J Dermatol. 2009;160(6):1273-85.

Riddle CC, Terrell SN, Menser MB, Aires DJ, Schweiger ES. A review of photodynamic therapy (PDT) for the treatment of acne vulgaris. J Drugs Dermatol. 2009;8(11):1010-9.

Magin PJ, Adams J, Pond CD, Smith W. Topical and oral CAM in acne: a review of the empirical evidence and a consideration of its context. Complement Ther Med. 2006;14(1):62-76.

Downloads

Publicado

2013-05-05

Como Citar

1.
Costa CS, Bagatin E. Evidências sobre o tratamento da acne. Sao Paulo Med J [Internet]. 5º de maio de 2013 [citado 15º de outubro de 2025];131(3):193-7. Disponível em: https://periodicosapm.emnuvens.com.br/spmj/article/view/1298

Edição

v. 131 n. 3 (2013)

Seção

Artigo de Revisão

Licença

Creative Commons License
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.